Bristol Myers Squibb today announced Week 52 data from the pivotal Phase 3 POETYK PsA-1 trial further confirming the efficacy and safety of Sotyktu (deucravacitinib) in adults with active psoriatic ...
On this "Face the Nation with Margaret Brennan" broadcast, Treasury Secretary Scott Bessent and House Minority Hakeem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback